According to Jazz Pharmaceuticals's latest financial reports the company's total debt is $5.79 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $5.79 B | -0.35% |
2022-12-31 | $5.81 B | -5.54% |
2021-12-31 | $6.15 B | 173.54% |
2020-12-31 | $2.24 B | 26.99% |
2019-12-31 | $1.77 B | 10.95% |
2018-12-31 | $1.59 B | 0.97% |
2017-12-31 | $1.58 B | -22.1% |
2016-12-31 | $2.02 B | 70.78% |
2015-12-31 | $1.18 B | -11.47% |
2014-12-31 | $1.34 B | 144.09% |
2013-12-31 | $0.54 B | 20.41% |
2012-12-31 | $0.45 B | |
2010-12-31 | $48.04 M | -61.34% |
2009-12-31 | $0.12 B | 1.52% |
2008-12-31 | $0.12 B | 55.79% |
2007-12-31 | $78.57 M | 2.75% |
2006-12-31 | $76.47 M | 3.86% |
2005-12-31 | $73.62 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Novartis NVS | $26.34 B | 354.93% | ๐จ๐ญ Switzerland |
AmerisourceBergen
ABC | $5.02 B | -13.31% | ๐บ๐ธ USA |
Endo International
ENDPQ | $5.08 M | -99.91% | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | $20.15 B | 247.97% | ๐ฎ๐ฑ Israel |